Silexion Therapeutics Corp. (NASDAQ: SLXN) ("Silexion" or the "Company"), a clinical-stage biotechnology company pioneering ...

Daphnia, also known as water fleas, are artists of defense. When their predators live nearby, the water fleas change their ...

Late-breaking abstract for BB-301 presented at the Muscular Dystrophy Association (MDA) Clinical and Scientific Conference in March demonstrated ...

Children's Hospital of Philadelphia (CHOP) is pleased to announce that Beverly L. Davidson, PhD, Director of the Raymond G.

Scientists at the University of Maryland, Baltimore County, have uncovered a crucial trick used by enteroviruses—the group behind diseases like polio, myocarditis, encephalitis, and even the common ...

SIRPα targeted immunotherapy market offers significant opportunities: blocking CD47 promotes anti-tumor activity, with over 20 distinct molecules in clinical development. Key focus areas include ...

Researchers at the University of Maryland, Baltimore County (UMBC) have uncovered a crucial step that enteroviruses use to reproduce inside human ...

B cash runway to mid-2029, pivotal SCD & AATD programs, and attractive valuation—review risks and opportunities now.

Preclinical AVB-406 data presented in three oral presentations demonstrate the power of the vMiXTM RNAi platform and support planned clinical initiation for Alzheimer’s disease by the end of 2026 Prec ...

Madrigal licensed ARO-PNPLA3 from Arrowhead for $25 million upfront and up to $975 million in milestones, expanding a liver-directed siRNA portfolio intended to pair with resmetirom. PNPLA3 silencing ...

The oligonucleotides clinical trial analysis report delivers important insights into ongoing research on 600+ ...

But methyl groups aren’t easily passed to the next generation: Fertilized eggs erase most of these marks from both sets of ...